HARBIN, China, May 14 /PRNewswire-Asia/ -- China Sky One Medical, Inc. ("China Sky One Medical" or "the Company") (Nasdaq: CSKI), a leading fully integrated pharmaceutical company in the People's Republic of China ("PRC"), today announced that it will conduct a conference call at 8:00 a.m. Eastern Time on Tuesday, May 18, 2010, to discuss its first quarter of 2010 financial results.
Joining Mr. Yan-qing Liu, Chairman and CEO of China Sky One Medical, will be Stanley Hao, Chief Financial Officer. The Company plans to issue an earnings announcement prior to the call.
To participate in the live conference call, please dial the following number five to ten minutes prior to the scheduled conference call time:
877-585-2309. International callers should dial 706-902-4207. The Conference ID for this call is 73235080.
If you are unable to participate in the call at this time, a replay will be available for two weeks starting on Tuesday, May 18, 2010 at 9:00 a.m. EDT. To access the replay, dial 800-642-1687, international callers dial
706-645-9291. The Conference Replay Passcode is 73235080.
About China Sky One Medical, Inc.
China Sky One Medical, Inc., a Nevada corporation, is a holding company. The Company engages in the manufacturing, marketing and distribution of pharmaceutical, medicinal and diagnostic products. Through its wholly-owned subsidiaries, Harbin Tian Di Ren Medical Science and Technology Company ("TDR"), Harbin First Bio-Engineering Company Limited ("First"), Heilongjiang Tianlong Pharmaceutical, Inc. ("Tianlong") and Peng Lai Jin Chuang Pharmaceutical Company ("Jin Chuang") the Company manufactures and distributes over-the-counter pharmaceutical products, which make up its major revenue source. For more information, visit http://www.cski.com.cn .
